Clinical trial
Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary…
NCT00071461 · Actelion, Industry · Completed
Key facts
| NCT number | NCT00071461 |
|---|---|
| Title | Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis |
| Official title | A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Bosentan in Patients With Idiopathic Pulmonary Fibrosis, Open Label Extension |
| Acronym | BUILD 1 |
| Lead sponsor | Actelion, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Idiopathic Pulmonary Fibrosis |
| Intervention type | Drug |
| Interventions | bosentan, Placebo |
| Enrollment | 158 |
| Start date | Aug 1, 2003 |
| Primary completion | Sep 1, 2005 |
| Completion | May 1, 2010 |
| First posted | Oct 24, 2003 |
| Last update posted | Feb 24, 2012 |
| Countries | Canada, France, Germany, Israel, Italy, Switzerland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: